Biotech
DENVER, CO: DENVER, CO -- (Marketwire) -- 05/30/12 -- (OTCBB: OMBP), a biopharmaceutical company, today announced the most recent results from its human clinical trial in Type 1 diabetes (the "Trial") ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 05/30/12 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim President & CEO ...
SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 05/30/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- College campuses across North America are winding up another academic year ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 05/29/12 -- MethylGene Inc. (TSX: MYG) today announced that clinical data for its Met/VEGF-R kinase inhibitor, MGCD265, will be presented at the 2012 ASCO Annual ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 05/29/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the Jefferies 2012 Global Healthcare Conference in New York on ...
VANCOUVER, CANADA: VANCOUVER, CANADA -- (Marketwire) -- 05/29/12 -- The Centre for Drug Research and Development (CDRD), its commercial arm, CDRD Ventures Inc. (CVI), and GlaxoSmithKline (GSK) in Canada are pleased to ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 05/29/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company developing the pate ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 05/29/12 -- Paladin Labs Inc. ("Paladin" or the "Company")(TSX: PLB), a leading Canadian specialty pharmaceutical company, today announces the ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 05/29/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that its board of directors has approved an increase of approximately $10.5 million to the ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 05/28/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company developing the pate ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 05/28/12 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company") today released financial results for the quarter ended March 31, 2012 ...
MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO: MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO -- (Marketwire) -- 05/28/12 -- May 28, 2012 - Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company and Nuvo Research Inc. (TSX: NRI), a ...
CARY, NC: CARY, NC -- (Marketwire) -- 05/24/12 -- Inc. (NASDAQ: CRTX) today announced that on May 18, 2012 the United States District Court for the Western District of New York issued a decision and order gr ...
HALIFAX, NOVA SCOTIA: - New vaccine collaborations in infectious diseases and cocaine addiction validate the promise of Immunovaccine's technologies - Successful private placement raises $2.8 million ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 05/24/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that Dr. Wayne Danter, President and CEO, has been invited to deliver a pr ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 05/23/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") advises of the following changes to senior management and t ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 05/23/12 -- MethylGene Inc. (TSX: MYG) today announced that Mr. Joseph Walewicz, Vice President, Business and Corporate Development, will present an overview of t ...
DOYLESTOWN, PA: DOYLESTOWN, PA -- (Marketwire) -- 05/23/12 -- RadMD, LLC announces the opening of its European office to expand services to EU pharma, biotech, and medical device companies.The new location will pro ...
